RNS Number:1343U
Pace Micro Technology PLC
12 January 2004

                                   SCHEDULE 5


The following replaces the Blocklisting Interim Review announcement released on
                       12-11-2003 under RNS number 9982R.

  Section 5, Number of shares issued / allotted under scheme during period, is
                   nil, and not 41,904 as previously stated.

 Section 6, Balance under scheme not yet issued / allotted at end of period, is
                 858,178, and not 816,274 as previously stated.

  All other details remain unchanged and the full, amended text appears below.


                 BLOCKLISTING SIX MONTHLY RETURN - REPLACEMENT

To:     Listing Applications

UK Listing Authority

Financial Services Authority

25, The North Colonnade

Canary Wharf

London, E14 5HS
AVS No:

               Please ensure the entries on this return are typed


1. Name of company
Pace Micro Technology plc

2. Name of scheme
Sharesave

3. Period of return:
From       7 May 2003                                To     6 November 2003

4. Number and class of shares(s) (amount of stock / debt security) not issued
under scheme
858,178 ordinary 5p shares

5. Number of shares issued / allotted under scheme during period:
Amendment: Nil

6. Balance under scheme not yet issued / allotted at end of period
858,178

7. Number and class of share(s) (amount of stock / debt securities) originally
listed and the date of admission;
1,000,000 ordinary 5p shares admitted on 7 May 1998

Please confirm total number of shares in issue at the end of the period in order
for us to update our records
226,311,231 ordinary 5p shares

Contact for queries
Name              Caroline Hall

Address           Pace Micro Technology plc
                  Victoria Road
                  Saltaire
                  Shipley
                  West Yorkshire
                  BD18 3LF

Telephone         01274 537119

Person making the return
Name              Anthony Dixon
Position          Company Secretary
Signature         Anthony Dixon

The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

BLRUUONRSVRAAAR